AstraZeneca (AZN)
(Delayed Data from NSDQ)
$68.55 USD
+0.19 (0.28%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $68.56 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth F Momentum D VGM
Income Statements
Fiscal Year end for AstraZeneca PLC falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 45,811 | 44,351 | 37,417 | 26,617 | 24,384 |
Cost Of Goods | 8,268 | 12,391 | 12,437 | 5,299 | 4,921 |
Gross Profit | 37,543 | 31,960 | 24,980 | 21,318 | 19,463 |
Selling & Adminstrative & Depr. & Amort Expenses | 29,350 | 28,203 | 23,924 | 16,156 | 16,539 |
Income After Depreciation & Amortization | 8,193 | 3,757 | 1,056 | 5,162 | 2,924 |
Non-Operating Income | 332 | 90 | -21 | 60 | 56 |
Interest Expense | 1,626 | 1,346 | 1,300 | 1,306 | 1,432 |
Pretax Income | 6,899 | 2,501 | -265 | 3,916 | 1,548 |
Income Taxes | 938 | -792 | -380 | 772 | 321 |
Minority Interest | 6 | 5 | 3 | -52 | -108 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 5,961 | 3,293 | 115 | 3,144 | 1,227 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 5,955 | 3,288 | 112 | 3,196 | 1,335 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 13,580 | 9,237 | 7,586 | 8,311 | 6,686 |
Depreciation & Amortization (Cash Flow) | 5,387 | 5,480 | 6,530 | 3,149 | 3,762 |
Income After Depreciation & Amortization | 8,193 | 3,757 | 1,056 | 5,162 | 2,924 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 3,124.00 | 3,120.00 | 2,854.00 | 2,626.00 | 2,602.00 |
Diluted EPS Before Non-Recurring Items | 3.63 | 3.33 | 2.65 | 2.01 | 1.75 |
Diluted Net EPS (GAAP) | 1.91 | 1.06 | 0.04 | 1.22 | 0.52 |
Fiscal Year end for AstraZeneca PLC falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 12,024.00 | 11,492.00 | 11,416.00 | 10,879.00 |
Cost Of Goods | NA | 2,308.00 | 2,095.00 | 1,960.00 | 1,905.00 |
Gross Profit | NA | 9,716.00 | 9,397.00 | 9,456.00 | 8,974.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 8,482.00 | 7,443.00 | 7,000.00 | 6,425.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 1,234.00 | 1,954.00 | 2,456.00 | 2,549.00 |
Non-Operating Income | NA | 101.00 | 90.00 | 63.00 | 78.00 |
Interest Expense | NA | 438.00 | 392.00 | 431.00 | 365.00 |
Pretax Income | NA | 897.00 | 1,652.00 | 2,088.00 | 2,262.00 |
Income Taxes | NA | -62.00 | 274.00 | 268.00 | 458.00 |
Minority Interest | NA | -1.00 | 4.00 | 2.00 | 1.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 959.00 | 1,378.00 | 1,820.00 | 1,804.00 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 960.00 | 1,374.00 | 1,818.00 | 1,803.00 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 3,122.00 | 3,120.00 | 3,120.00 | 3,120.00 |
Diluted EPS Before Non-Recurring Items | NA | 0.73 | 0.87 | 1.08 | 0.96 |
Diluted Net EPS (GAAP) | NA | 0.30 | 0.44 | 0.58 | 0.58 |